FIELD: chemistry.
SUBSTANCE: invention relates to a method of altering immunomodulating properties of lipopolysaccharides of plague bacteria in vitro, which involves obtaining preparations of lipopolysaccharides (LPS) and mouse toxin (MT) Yersinia pestis with subsequent formation of a LPS-MT complex thereof. A modified form of LPS-MT is used as an inducer of synthesis of cytotoxins TNF-α and IFN-γ. To this end, a test sample is prepared, to which LPS is added in amount of 5 mcg (50 mcl from working dilution of 100 mcl/ml) and MT is added in amount of 50 ng (5 mcl from working dilution of 10 mcg/ml); the sample is then incubated for 30 min at 37°C. The volume of the sample in eppendorfs is then brought to 100 mcl with sterile buffered physiological solution of NaCl and the obtained mixture is added a tray dimple containing a culture of human monocyte cell line U-937 (1×106 cells in a dimple); the latter is cultured in a medium of PRMI 1640 with simultaneous double control. Further, 1, 4, 20 hours after the beginning of combined incubation of the preparations of LPS with monocytes, quantitative accounting of the synthesised cytotoxins is carried out, wherein change in the immunomodulating properties of LPS of plague bacteria in vitro is determined from the amount of cytotoxins produced and the dynamics of their synthesis.
EFFECT: invention enables to alter immunomodulating properties of lipopolysaccharides of plague bacteria in vitro, which enables to realise toxic potential of the endotoxin of plague bacteria.
2 cl, 8 dwg, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF DIFFERENTIATING STRAINS OF YERSINIA PESTIS INTO TOXICALLY ACTIVE AND INACTIVE ONES | 2017 |
|
RU2663133C1 |
METHOD FOR SELECTION OF SUBSTANCES FOR DIRECTED IMMUNE RESPONSE MODULATION AFTER VACCINATION AGAINST PLAGUE | 2016 |
|
RU2621303C1 |
PROTEIN CAUSEING CELL AUTOAGGLUTINATION PROPERTY OF PLAGUE MICROBES, AND METHOD FOR PRODUCING IT | 2011 |
|
RU2473558C1 |
METHOD OF ISOLATION OF SECRETION INHIBITOR OF SIDEROPHORES SYNTHESISED BY PGMSTRAINS Y. pestis AND ISOLATED INHIBITOR | 2013 |
|
RU2549712C1 |
METHOD OF MELIOIDOZE ANTIGEN ESTIMATE FOR PROTECTIVITY LEVEL | 2007 |
|
RU2354400C1 |
RECOMBINANT PLASMID EXPRESSING CLONED GENES OF BIOSYNTHESIS OF YERSINIA SIDEROPHORE PESTIS, METHOD OF ITS PRODUCTION AND YERSINIA PESTIS – YERSINIA SUPERPRODUCENT STRAIN | 2017 |
|
RU2670949C9 |
METHOD AND COMPOSITION FOR DETERMINING IMMUNOGENIC ACTIVITY OF BIOLOGICALLY-ACTIVE COMPOUNDS | 1992 |
|
RU2125727C1 |
COMPOSITIONS CONTAINING FETAL HEMOGLOBIN AND BACTERIAL ENDOTOXIN AND OPTIONALLY, FETAL LIVER ADDITIVE | 2004 |
|
RU2366449C2 |
METHOD OF TREATING LICHEN ACUMINATUS IN ORAL MUCOSA | 2011 |
|
RU2510269C2 |
METHOD FOR Yersinia pestis Yersinia pseudotuberculosis STRAIN IDENTIFICATION | 2010 |
|
RU2422535C1 |
Authors
Dates
2013-08-10—Published
2011-12-28—Filed